Skip to main content
. 2022 Jun 6;11(11):3239. doi: 10.3390/jcm11113239

Figure 6.

Figure 6

Forest plots and funnel plots for hospital mortality improvement between colistin monotherapy and colistin plus meropenem combination therapy. Seven studies involving 1269 patients (596 with colistin monotherapy, 673 with colistin plus meropenem combination therapy) reported hospital mortality or 28-day mortality. There was no significant difference in hospital mortality or 28-day mortality between patients treated with colistin monotherapy and colistin plus meropenem combination therapy [24,25,26,28,29,31,32].